![A biochemical approach to discriminate between ATP-competitive and non-ATP-competitive protein kinase inhibitors](https://www.reactionbiology.com/wp-content/uploads/2023/07/Mueller_AACR_2017_newlayout_thumb.png)
![A biochemical approach to discriminate between ATP-competitive and non-ATP-competitive protein kinase inhibitors](https://www.reactionbiology.com/wp-content/uploads/2023/07/Mueller_AACR_2017_newlayout_thumb.png)
![N-Alkylated sulfamides as neutral solubility improving groups for kinase inhibitors](https://www.reactionbiology.com/wp-content/uploads/2023/07/Sulfamides_Poster_thumbnail.png)
N-Alkylated sulfamides as neutral solubility improving groups for kinase inhibitors
![A high-throughput soft agar assay on a panel of 60 tumor cell lines.](https://www.reactionbiology.com/wp-content/uploads/2023/07/687-Soft-Agar_Poster_Reaction-Biology.png)
A high-throughput soft agar assay on a panel of 60 tumor cell lines.
![Analysis of the combinatorial anti-proliferative effect of panRAF inhibitor AZ-628 and MEK1 inhibitor AZD-6244 (selumetinib) on a large panel of tumor cell lines 2017, presented at AACR](https://www.reactionbiology.com/wp-content/uploads/2023/07/Antiproliferative-effect-tumor-cell-lines-Poster-thumbnail.png)
Analysis of the combinatorial anti-proliferative effect of panRAF inhibitor AZ-628 and MEK1 inhibitor AZD-6244 (selumetinib) on a large panel of tumor cell lines 2017, presented at AACR
![Characterization of KRas pathway inhibitors in 2D and 3D screening formats](https://www.reactionbiology.com/wp-content/uploads/2023/06/ReactionBiology_KRAS-2D3D_Poster_0.png)